CD44 and cancer: In our study, five DEPs (CD44, Stat3, CAMK2D, CAMK2B and CAMK2G) were identified in the proteoglycans in cancer signaling pathway, which worked together to modulate functions of this pathway, such as cell migration and invasion, cell adhesion, cell growth and survival (Figure 4A).